Market Definition
Hematology diagnostics is the study of blood and blood disorders. It is used to diagnose, monitor, and treat a variety of disorders and conditions that affect the blood, including anemia, bleeding disorders, and blood cancers such as leukemia and lymphoma. Diagnostic tests are used to measure levels of red and white blood cells, platelets, hemoglobin, and other components of blood. In addition, tests can detect abnormalities such as abnormal shapes, sizes, and numbers of blood cells, as well as changes in blood clotting factors. Imaging tests, such as ultrasound and MRI, may also be used to help diagnose and monitor blood disorders.
Market Insights
According to MarkNtel Advisors’ research report, “Global Hematology Diagnostics Market Analysis, 2021,” the market is likely to grow at a CAGR of around 6.9% during 2021-26. The prime factors contributing to the growth of hematology diagnostics across the globe are the technological advancements for new automated analyzers & testers and rising blood-related disorders across both children & elders. Moreover, the rising geriatric population & the number of blood disorder-related incidents are other crucial aspects likely to surge the overall market growth of hematology diagnostics across the globe.
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2016-19 |
| Base Year: 2020 | |
| Forecast Period: 2021-26 | |
| CAGR (2022-2027) | 6.9% |
| Regions Covered | North America: USA, Canada, Mexico |
| Europe: Germany, UK, France, Italy, Spain, Russia | |
| Asia-Pacific: China, India, Japan, South Korea, Australia | |
| South America: Brazil, and Argentina | |
| Middle East & Africa: UAE, Saudi Arabia, South Africa | |
| Key Companies Profiled | Abbott Laboratories, Mindray Medical International, Siemens Healthneers, BioSystems, BioRad Laboratories, Horiba, Sysmex Corporation, Nihon Kohden Corporation, Danaher Corporation, F. Hoffman-La-Roche Ltd. |
| Unit Denominations | USD Million/Billion |
Impact of COVID-19
The sudden outbreak of the COVID-19 pandemic has impacted most industries due to nationwide lockdown and other stringent restrictions. Initially, the Hematology Diagnostics Market faced challenges due to supply chain disruptions, movement restrictions, and varying demand for different products. However, the widespread pandemic has also pushed the Hematology Diagnostics Market into action by generating new opportunities to develop rapid COVID-19 testing kits. Hence, this aspect is very likely to propel the overall market growth in the forecast period.
Market Segmentation
Hematology Analyzer Accounted for the Largest Market Share
Based on the Product, the market bifurcates into Hematology Instruments, Hematology Analyzers, Fully-Automated Hematology Analyzers, Semi-Automated Hematology Analyzers, and Flow Cytometers. Of them all, Hematology Analyzers acquired the largest share in the Global Hematology Diagnostics Market in the previous few years. It attributes to the mounting automation and technological advancements in the field. In addition to this, rising demand for advanced instruments that can offer better reliability, sensitivity, safety, and ease of operation further propels the demand for Hematology Analyzers, cites MarkNtel Advisors’ in their research report “Global Hematology Diagnostics Market Analysis, 2021”.
Reagents Dominated the Market
Based on the Consumables, the market classifies them into Reagents, Stains, Controls, and Calibrations. Among these segments, Reagents dominated the Global Hematology Diagnostics Market with a significant share in the previous few years. It mainly owes to the increasing diagnosis of blood disorders and other types of infections. Besides, rising awareness regarding the diagnosis process and early detection has led to aid the number of tests, thereby propelling the segment growth.
Regional Landscape
North America Leads the Market with the Highest Share
Geographically, North America has been leading the Global Hematology Diagnostics Market with the highest share for the past few years, primarily due to the abundant presence of diagnostic centers. In addition to this, an increase in the investments to enhance research and development activities and burgeoning adoption of technologically advanced diagnostics are other essential aspects driving the Global Hematology Diagnostics Market in North America.
Market Drivers
Rising Incidences of Blood-Related Diseases to Boost the Market
The surging blood-related disorders like anemia, blood cancer, hemophilia, and blood clots among children and elders are the prime factors likely to fuel the Global Hematology Diagnostics Market. Additionally, the growing world population suffering from different Hemoglobinopathies is another crucial aspect that shall boost the overall market growth globally in the forecast period.
Market Challenges
Unfavorable Reimbursement Policies
The prime factors restraining the market growth are inadequate healthcare insurance coverage and the high cost of diagnostic procedures. In addition to this, the lack of awareness regarding the diagnostic processes and stringent reimbursement policies are other critical aspects that could hinder the overall market growth during the forecast period.
Competitive Landscape
According to MarkNtel Advisors, the major leading players in the global Hematology Diagnostics market are Abbott Laboratories, Mindray Medical International, Siemens Healthneers, BioSystems, BioRad Laboratories, Horiba, Sysmex Corporation, Nihon Kohden Corporation, Danaher Corporation, F. Hoffman-La-Roche Ltd., etc.
Key Questions Answered in the Market Research Report:
Market Outlook, Segmentation, and Statistics
Frequently Asked Questions
A. The Global Hematology Diagnostics Market is forecast to grow at a CAGR of 6.9% during 2021-26.
A. Abbott Laboratories, Mindray Medical International, Siemens Healthneers, BioSystems, BioRad Laboratories, Horiba, Sysmex Corporation, Nihon Kohden Corporation, Danaher Corporation, F. Hoffman-La-Roche Ltd. are a few of the leading players in the Global Hematology Diagnostics Market.
A. The Hematology Analyzer segment is likely to attain the highest CAGR during the forecast period and maintain its significant market share.
A. North America continues to grow at the highest CAGR during 2021-26, thereby presenting immense opportunities to market players of the Global Hematology Diagnostics Market.
A. Rising development of condition-specific treatment, booming awareness regarding personalized medicines, increase in the number of blood donations, rising prevalence of blood disorders, and technological advancements in hematology are the prime factors fueling the market growth.
A. The widespread pandemic has also pushed the Hematology Diagnostics market into action by generating new opportunities to develop rapid COVID-19 testing kits, thereby propelling the market growth in the forecast period.
1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Assumptions
1.4. Market Segmentation
2. Executive Summary
3. Expert Verbatim- What our Experts Say?
4. Global Hematology Diagnostics Market Analysis, 2015-2025F
4.1. Market Size & Analysis
4.1.1. Market Revenue
4.2. Market Share & Analysis
4.2.1. By Product Type
4.2.1.1. Hematology Instruments
4.2.1.2. Hematology Analyzer
4.2.1.3. Fully-automated hematology analyzer
4.2.1.4. Semi-automated hematology analyzer
4.2.1.5. Flow cytometers
4.2.1.6. Others
4.2.2. By End User
4.2.2.1. Hospitals and Clinics
4.2.2.2. Diagnostic Laboratories
4.2.2.3. Academic Institute
4.2.2.4. Commercial Service Providers
4.2.2.5. Others
4.2.3. By Consumables
4.2.3.1. Reagents
4.2.3.2. Stains
4.2.3.3. Controls and Calibrations
4.2.3.4. Others
4.2.4. By Region
4.2.4.1. North America
4.2.4.2. South America
4.2.4.3. Europe
4.2.4.4. Middle East & Africa
4.2.4.5. Asia-Pacific
4.2.5. By Company
4.2.5.1. Revenue Shares
4.2.5.2. Strategic Factorial Indexing
4.2.5.3. Competitor Placement in MarkNtel Quadrant
5. North America Hematology Diagnostics Market Analysis, 2015-2025F
5.1. Market Size & Analysis
5.1.1. Market Revenue
5.2. Market Share & Analysis
5.2.1. By Product Type
5.2.2. By End User
5.2.3. By Consumables
5.2.4. By Country
5.2.4.1. United States
5.2.4.2. Canada
5.2.4.3. Mexico
5.3. United States Hematology Diagnostics Market Analysis, 2015-2025F
5.3.1. Market Size & Analysis
5.3.1.1. Market Revenue
5.3.2. Market Share & Analysis
5.3.2.1. By Product Type
5.3.2.2. By End User
5.3.2.3. By Consumables
5.4. Canada Hematology Diagnostics Market Analysis, 2015-2025F
5.4.1. Market Size & Analysis
5.4.1.1. Market Revenue
5.4.2. Market Share & Analysis
5.4.2.1. By Product Type
5.4.2.2. By End User
5.4.2.3. By Consumables
5.5. Mexico Hematology Diagnostics Market Analysis, 2015-2025F
5.5.1. Market Size & Analysis
5.5.1.1. Market Revenue
5.5.2. Market Share & Analysis
5.5.2.1. By Product Type
5.5.2.2. By End User
5.5.2.3. By Consumables
6. South America Hematology Diagnostics Market Analysis, 2015-2025F
6.1. Market Size & Analysis
6.1.1. Market Revenue
6.2. Market Share & Analysis
6.2.1. By Product Type
6.2.2. By End User
6.2.3. By Consumables
6.2.4. By Country
6.2.4.1. Brazil
6.2.4.2. Argentina
6.3. Brazil Hematology Diagnostics Market Analysis, 2015-2025F
6.3.1. Market Size & Analysis
6.3.1.1. Market Revenue
6.3.2. Market Share & Analysis
6.3.2.1. By Product Type
6.3.2.2. By End User
6.3.2.3. By Consumables
6.4. Argentina Hematology Diagnostics Market Analysis, 2015-2025F
6.4.1. Market Size & Analysis
6.4.1.1. Market Revenue
6.4.2. Market Share & Analysis
6.4.2.1. By Product Type
6.4.2.2. By End User
6.4.2.3. By Consumables
7. Europe Hematology Diagnostics Market Analysis, 2015-2025F
7.1. Market Size & Analysis
7.1.1. Market Revenue
7.2. Market Share & Analysis
7.2.1. By Product Type
7.2.2. By End User
7.2.3. By Consumables
7.2.4. By Country
7.2.4.1. France
7.2.4.2. Germany
7.2.4.3. Italy
7.2.4.4. United Kingdom
7.2.4.5. Spain
7.3. France Hematology Diagnostics Market Analysis, 2015-2025F
7.3.1. Market Size & Analysis
7.3.1.1. Market Revenue
7.3.2. Market Share & Analysis
7.3.2.1. By Product Type
7.3.2.2. By End User
7.3.2.3. By Consumables
7.4. Germany Hematology Diagnostics Market Analysis, 2015-2025F
7.4.1. Market Size & Analysis
7.4.1.1. Market Revenue
7.4.1.2. Units Sold
7.4.2. Market Share & Analysis
7.4.2.1. By Product Type
7.4.2.2. By End User
7.4.2.3. By Consumables
7.5. Italy Hematology Diagnostics Market Analysis, 2015-2025F
7.5.1. Market Size & Analysis
7.5.1.1. Market Revenue
7.5.2. Market Share & Analysis
7.5.2.1. By Product Type
7.5.2.2. By End User
7.5.2.3. By Consumables
7.6. United Kingdom Hematology Diagnostics Market Analysis, 2015-2025F
7.6.1. Market Size & Analysis
7.6.1.1. Market Revenue
7.6.2. Market Share & Analysis
7.6.2.1. By Product Type
7.6.2.2. By End User
7.6.2.3. By Consumables
7.7. Spain Hematology Diagnostics Market Analysis, 2015-2025F
7.7.1. Market Size & Analysis
7.7.1.1. Market Revenue
7.7.2. Market Share & Analysis
7.7.2.1. By Product Type
7.7.2.2. By End User
7.7.2.3. By Consumables
8. Middle East and Africa Hematology Diagnostics Market Analysis, 2015-2025F
8.1. Market Size & Analysis
8.1.1. Market Revenue
8.2. Market Share & Analysis
8.2.1. By Product Type
8.2.2. By End User
8.2.3. By Consumables
8.2.4. By Country
8.2.4.1. UAE
8.2.4.2. Saudi Arabia
8.3. UAE Hematology Diagnostics Market Analysis, 2015-2025F
8.3.1. Market Size & Analysis
8.3.1.1. Market Revenue
8.3.2. Market Share & Analysis
8.3.2.1. By Product Type
8.3.2.2. By End User
8.3.2.3. By Consumables
8.4. Saudi Arabia Hematology Diagnostics Market Analysis, 2015-2025F
8.4.1. Market Size & Analysis
8.4.1.1. Market Revenue
8.4.2. Market Share & Analysis
8.4.2.1. By Product Type
8.4.2.2. By End User
8.4.2.3. By Consumables
8.5. South Africa Hematology Diagnostics Market Analysis, 2015-2025F
8.5.1. Market Size & Analysis
8.5.1.1. Market Revenue
8.5.2. Market Share & Analysis
8.5.2.1. By Product Type
8.5.2.2. By End User
8.5.2.3. By Consumables
9. Asia-Pacific Hematology Diagnostics Market Analysis, 2015-2025F
9.1. Market Size & Analysis
9.1.1. Market Revenue
9.2. Market Share & Analysis
9.2.1. By Product Type
9.2.2. By End User
9.2.3. By Consumables
9.2.4. By Country
9.2.4.1. China
9.2.4.2. India
9.2.4.3. Japan
9.2.4.4. Australia
9.2.4.5. South Korea
9.3. China Hematology Diagnostics Market Analysis, 2015-2025F
9.3.1. Market Size & Analysis
9.3.1.1. Market Revenue
9.3.2. Market Share & Analysis
9.3.2.1. By Product Type
9.3.2.2. By End User
9.3.2.3. By Consumables
9.4. India Hematology Diagnostics Market Analysis, 2015-2025F
9.4.1. Market Size & Analysis
9.4.1.1. Market Revenue
9.4.2. Market Share & Analysis
9.4.2.1. By Product Type
9.4.2.2. By End User
9.4.2.3. By Consumables
9.5. Japan Hematology Diagnostics Market Analysis, 2015-2025F
9.5.1. Market Size & Analysis
9.5.1.1. Market Revenue
9.5.2. Market Share & Analysis
9.5.2.1. By Product Type
9.5.2.2. By End User
9.5.2.3. By Consumables
9.6. Australia Hematology Diagnostics Market Analysis, 2015-2025F
9.6.1. Market Size & Analysis
9.6.1.1. Market Revenue
9.6.2. Market Share & Analysis
9.6.2.1. By Product Type
9.6.2.2. By End User
9.6.2.3. By Consumables
9.7. South Korea Hematology Diagnostics Market Analysis, 2015-2025F
9.7.1. Market Size & Analysis
9.7.1.1. Market Revenue
9.7.2. Market Share & Analysis
9.7.2.1. By Product Type
9.7.2.2. By End User
9.7.2.3. By Consumables
10. Global Hematology Diagnostics Market Policies, Regulations, Product Standards
11. Global Hematology Diagnostics Market Trends & Insights
12. Global Hematology Diagnostics Market Dynamics
12.1.Growth Drivers
12.2.Challenges
12.3.Impact Analysis
13. Global Hematology Diagnostics Market Hotspot & Opportunities
14. Global Hematology Diagnostics Market Key Strategic Imperatives for Success & Growth
15. Global Competition Outlook
15.1. Competition Matrix
15.1.1. Product Portfolio
15.1.2. Brand Specialization
15.1.3. Target Markets
15.1.4. Target End Users
15.1.5. Research & Development
15.1.6. Strategic Alliances
15.1.7. Strategic Initiatives
15.2. Company Profiles (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
15.2.1. Abbott Laboratories
15.2.2. Mindray Medical International
15.2.3. Siemens Healthneers
15.2.4. BioSystems
15.2.5. BioRad Laboratories
15.2.6. Horiba
15.2.7. Symex Corporation
15.2.8. Nihon Kohden Corpration
15.2.9. Danaher Corporation
15.2.10. F. Hoffman-La-Roche Ltd.
16. Disclaimer
